Thyroid hormone therapy after lobectomy for low-risk thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a small thyroid nodule (4 cm or less) that is papillary thyroid cancer and you are planning to have a lobectomy (removing half of the thyroid).
- Cancer has not spread to lymph nodes (no clinical signs, and if any tiny spots found, no more than 5 and each smaller than 0.2 cm).
- You have no serious organ or blood problems, no other head or neck cancers, no prior neck radiation, and no deep neck surgery (except for skin lumps).
- You can commit to follow-up care and thyroid hormone therapy after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with low-risk papillary thyroid cancer. It compares two surgical approaches: one that removes just the thyroid gland, and another that also removes some lymph nodes in the center of the neck as a preventive measure. The goal is to see if removing these lymph nodes helps prevent the cancer from coming back.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study tests whether taking thyroid hormone to lower TSH (a hormone that can stimulate thyroid cancer) is necessary for people with very small, low-risk thyroid cancers who choose active surveillance (monitoring instead of immediate surgery). It aims to find out if skipping this treatment is safe and helps avoid side effects.
This study tests whether a surgical technique that preserves the thymus during thyroid cancer removal can protect the parathyroid glands, which help control calcium levels. The goal is to reduce complications while still removing the cancer completely.
This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.